PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 172 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $662,806,000 | -29.5% | 11,800 | -50.8% | 0.13% | -25.1% |
Q1 2017 | $940,560,000 | +153.3% | 24,000 | +31.9% | 0.18% | +159.4% |
Q1 2016 | $371,280,000 | -60.3% | 18,200 | 0.0% | 0.07% | -57.1% |
Q4 2015 | $936,390,000 | +185.0% | 18,200 | +56.9% | 0.16% | +283.3% |
Q4 2014 | $328,512,000 | +4.8% | 11,600 | -6.5% | 0.04% | -4.5% |
Q3 2014 | $313,472,000 | -79.5% | 12,400 | -76.4% | 0.04% | -78.7% |
Q2 2014 | $1,531,950,000 | – | 52,500 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Grace Capital | 270,832 | $6,467,000 | 5.27% |
Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |